Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development

Overview of attention for article published in The Journal of Pathology, April 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 4 X users
patent: 8 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 186 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 3,030 followers.

@EliotBlatt @gr8straj @RJDLab @Ram_Mani_PhD @jodebon @oncogenejournal Really nice paper! Our previous data showed Gln uptake through ASCT2/SLC1A5 is AR regulated in PCa (https://t.co/90yF9MQbjg), and targetable (https://t.co/mJAuwTSxjH). You showed in…

RT @HumanPathology: J Pathol: Targeting ASCT2-Mediated Glutamine Uptake Blocks Prostate Cancer Growth and Tumour Development: Glut... http:…

RT @ProstateCell: Targeting ASCT2-Mediated Glutamine Uptake Blocks #ProstateCancer Growth & Tumor Development @Sydney_Uni http://t.co/231AQ…

Targeting ASCT2-Mediated Glutamine Uptake Blocks #ProstateCancer Growth & Tumor Development @Sydney_Uni http://t.co/231AQ5y8X6

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.